Lazertinib Related Products


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Lazertinib, pharmacopeial and non-pharmacopeial Lazertinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Lazertinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Lazertinib-related products are thoroughly characterized. Lazertinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Lazertinib

SZ目录编号:: SZ-L127001
CAS 号: 1903008-80-9
分子式: C30H34N8O3
分子量: 554.7
投资状态:
Rel. CAS No: 2247995-38-4 (HCl salt) ; 2247995-37-3 (Mesylate salt) ; 2247995-39-5(Citrate salt)

Lazertinib Impurity 1

SZ目录编号:: SZ-L127002
CAS 号: 2270204-98-1
分子式: C28H27N7O4
分子量: 525.6
投资状态:

Lazertinib Impurity 2

SZ目录编号:: SZ-L127003
CAS 号: 2270944-73-3
分子式: C30H35BrN8O3
分子量: 635.6
投资状态:

Lazertinib Impurity 3

SZ目录编号:: SZ-L127004
CAS 号: 1903009-56-2
分子式: C27H32N8O2
分子量: 500.6
投资状态:
Rel. CAS No: 2270944-71-1 (2HCl salt)

Lazertinib Impurity 4

SZ目录编号:: SZ-L127005
CAS 号: 1903010-39-8
分子式: C25H23N7O5
分子量: 501.5
投资状态:

Lazertinib Impurity 5

SZ目录编号:: SZ-L127006
CAS 号: 2270944-72-2
分子式: C30H35ClN8O3
分子量: 591.1
投资状态:
categories